Ticker
HBIOCompany Name
HARVARD BIOSCIENCE INCSector
HealthcareIndustry
Medical Instruments & SuppliesExchange
NASDAQDate | Enterprise Value | Enterprise Value over Free Cash Flow | Free Cash Flow |
---|---|---|---|
6/30/2025 | $ 55.75M | 13.5 | $ 4.13M |
3/31/2025 | $ 53.21M | 0 | $ -203K |
12/31/2024 | $ 67.79M | 0 | $ -1.82M |
9/30/2024 | $ 152.09M | 0 | $ -132K |
6/30/2024 | $ 172.41M | 28.9 | $ 5.96M |
3/31/2024 | $ 199.97M | 18.5 | $ 10.81M |
12/31/2023 | $ 234.22M | 19.99 | $ 11.72M |
9/30/2023 | $ 221.37M | 19.75 | $ 11.21M |
6/30/2023 | $ 232.99M | 32.03 | $ 7.27M |
3/31/2023 | $ 283.17M | 78.51 | $ 3.61M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
EV / FCF
(=) EV/FCF
EV/FCF for HARVARD BIOSCIENCE INC is calculated as follows: EV [ $ 193.59M ] / FCF [ $ 7.54M ]
(=) EV/FCF [ 25.69 ]
Minimum
Jun 30, 2025
Maximum
Dec 31, 2021
Average
Median
filtered constituents | 2.2K |
---|---|
min | 0.05 |
max | 77.98 |
average | 23.45 |
median | 19.08 |
std | 16.13 |